Correlation Between Virax Biolabs and Aquestive Therapeutics
Can any of the company-specific risk be diversified away by investing in both Virax Biolabs and Aquestive Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virax Biolabs and Aquestive Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virax Biolabs Group and Aquestive Therapeutics, you can compare the effects of market volatilities on Virax Biolabs and Aquestive Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virax Biolabs with a short position of Aquestive Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virax Biolabs and Aquestive Therapeutics.
Diversification Opportunities for Virax Biolabs and Aquestive Therapeutics
-0.5 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Virax and Aquestive is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and Aquestive Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aquestive Therapeutics and Virax Biolabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virax Biolabs Group are associated (or correlated) with Aquestive Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aquestive Therapeutics has no effect on the direction of Virax Biolabs i.e., Virax Biolabs and Aquestive Therapeutics go up and down completely randomly.
Pair Corralation between Virax Biolabs and Aquestive Therapeutics
Given the investment horizon of 90 days Virax Biolabs Group is expected to under-perform the Aquestive Therapeutics. In addition to that, Virax Biolabs is 1.62 times more volatile than Aquestive Therapeutics. It trades about -0.14 of its total potential returns per unit of risk. Aquestive Therapeutics is currently generating about -0.16 per unit of volatility. If you would invest 537.00 in Aquestive Therapeutics on August 24, 2024 and sell it today you would lose (86.00) from holding Aquestive Therapeutics or give up 16.01% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Virax Biolabs Group vs. Aquestive Therapeutics
Performance |
| Timeline |
| Virax Biolabs Group |
| Aquestive Therapeutics |
Virax Biolabs and Aquestive Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Virax Biolabs and Aquestive Therapeutics
The main advantage of trading using opposite Virax Biolabs and Aquestive Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virax Biolabs position performs unexpectedly, Aquestive Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aquestive Therapeutics will offset losses from the drop in Aquestive Therapeutics' long position.| Virax Biolabs vs. Revelation Biosciences | Virax Biolabs vs. Kiora Pharmaceuticals | Virax Biolabs vs. Quoin Pharmaceuticals Ltd | Virax Biolabs vs. Neurobo Pharmaceuticals |
| Aquestive Therapeutics vs. Evoke Pharma | Aquestive Therapeutics vs. Dynavax Technologies | Aquestive Therapeutics vs. Amphastar P | Aquestive Therapeutics vs. Lantheus Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |